| Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 | Mar'18 | |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development (includes related party amounts of $324, $363, $921, and $843, respectively) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
General and administrative (includes related party amounts of $83, $131, $241, and $267, respectively) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Total operating expenses | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Loss from operations | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Other income (expense): | ||||||
Change in fair value of preferred stock purchase right liability | ||||||
- | - | - | 0 | 0 | - | |
Interest income, net | ||||||
0 | 0 | 0 | - | - | - | |
Net loss | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net loss per common share, basic and diluted | ||||||
-0.38 | -0.39 | -0.35 | -23.06 | -4.21 | -2.32 | |
Weighted average common shares outstanding, basic and diluted | ||||||
31,788,314 | 31,561,445 | 31,430,071 | 965,137 | 951,066 | 942,605 | |